Bicocca Open Archive

Logo unimib boa
VETTORETTI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.501
NA - Nord America 2.092
EU - Europa 1.265
SA - Sud America 903
AF - Africa 100
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.864
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.986
SG - Singapore 1.306
VN - Vietnam 871
CN - Cina 817
BR - Brasile 639
HK - Hong Kong 612
IT - Italia 515
RU - Federazione Russa 308
BD - Bangladesh 304
KR - Corea 162
DE - Germania 111
AR - Argentina 110
FR - Francia 102
IN - India 101
IQ - Iraq 53
FI - Finlandia 45
CA - Canada 43
EC - Ecuador 41
ID - Indonesia 40
GB - Regno Unito 38
PK - Pakistan 38
ZA - Sudafrica 37
CO - Colombia 34
NL - Olanda 34
TR - Turchia 34
MX - Messico 33
VE - Venezuela 23
UZ - Uzbekistan 21
UA - Ucraina 20
JP - Giappone 19
PH - Filippine 19
MY - Malesia 18
SE - Svezia 17
AT - Austria 15
CL - Cile 14
PY - Paraguay 14
PE - Perù 13
KE - Kenya 12
PL - Polonia 12
SA - Arabia Saudita 12
TN - Tunisia 11
EG - Egitto 9
MA - Marocco 9
UY - Uruguay 9
ET - Etiopia 7
IE - Irlanda 7
KG - Kirghizistan 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
JM - Giamaica 6
NP - Nepal 6
AZ - Azerbaigian 5
JO - Giordania 5
KZ - Kazakistan 5
LB - Libano 5
RS - Serbia 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
CH - Svizzera 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ES - Italia 4
HN - Honduras 4
MM - Myanmar 4
OM - Oman 4
TH - Thailandia 4
TW - Taiwan 4
CI - Costa d'Avorio 3
IL - Israele 3
LT - Lituania 3
PA - Panama 3
PS - Palestinian Territory 3
QA - Qatar 3
RO - Romania 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
KH - Cambogia 2
KW - Kuwait 2
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
Totale 8.856
Salva come PNG Salva come JPEG
Città #
Singapore 677
Hong Kong 608
Hefei 339
San Jose 334
Ashburn 306
Ho Chi Minh City 267
Hanoi 235
Seoul 161
Dallas 145
Milan 135
The Dalles 104
Chicago 98
New York 78
Council Bluffs 77
Lauterbourg 76
Los Angeles 75
Buffalo 66
Frankfurt am Main 53
Rome 53
São Paulo 53
Boardman 52
Moscow 38
Ann Arbor 37
Da Nang 26
Haiphong 25
Beijing 24
Baghdad 23
Turin 23
Santa Clara 22
Curitiba 19
Biên Hòa 18
Orem 18
Tashkent 18
Lappeenranta 17
Thái Nguyên 17
Figino 16
Quận Bình Thạnh 16
Quận Một 16
Rio de Janeiro 16
Brasília 15
Dhaka 15
Munich 15
Naples 15
Thái Bình 15
Denver 14
Helsinki 14
Vũng Tàu 14
Can Tho 13
Guayaquil 13
Houston 13
Medellín 13
Mexico City 13
Toronto 13
Turku 13
Ha Long 12
Lahore 12
Nairobi 12
Phoenix 12
Quito 12
Seattle 12
Tokyo 12
Wenzhou 12
Belo Horizonte 11
Delhi 11
Jakarta 11
Salvador 11
Washington 11
Amsterdam 10
Bologna 10
Campinas 10
Hải Dương 10
Johannesburg 10
London 10
Xiamen 10
Bogotá 9
Erbil 9
Genoa 9
Guangzhou 9
Huế 9
Shanghai 9
Buenos Aires 8
Istanbul 8
Ninh Bình 8
Palermo 8
Phủ Lý 8
Salt Lake City 8
Warsaw 8
Asunción 7
Chandler 7
Charlotte 7
Chennai 7
Dublin 7
Montevideo 7
New Delhi 7
Nuremberg 7
Quận Bốn 7
San Francisco 7
Surabaya 7
São Gonçalo 7
Wilmington 7
Totale 5.011
Salva come PNG Salva come JPEG
Nome #
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 298
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 212
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 188
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 185
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 177
Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress 168
Peritoneal dialysis related peritonitis: insights from a long-term analysis of an Italian center 168
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 165
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: An Italian multicenter prospective study 163
Poor Nutritional Status Is Associated with Death in a Population of Dialyzed Older Persons 156
Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease 145
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives 143
Relationship between number of daily exchanges at CAPD start with clinical outcomes 141
Importance of blood pressure control in chronic kidney disease 140
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 139
Simultaneous removal and replacement of the peritoneal catheter in CAPD patient with refractory peritonitis sustained by P. aeruginosa: A case-report 138
Palliative and Supportive Dialysis: Current Practices and Recommendations for Best Clinical Practice 137
Serum uric acid and target organ damage in primary hypertension 137
Spontaneous low-protein intake in older CKD patients: one diet may not fit all 135
Frailty Is Associated with Malnutrition–Inflammation Syndrome in Older CKD Patients 130
Clinical Factors and Biomarkers Associated with Depressive Disorders in Older Patients Affected by Chronic Kidney Disease (CKD): Does the Advanced Glycation End Products (AGEs)/RAGE (Receptor for AGEs) System Play Any Role? 128
What's New in the CKD-BMD Therapy? 128
Corrigendum: Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study (Frontiers in Medicine, (2023), 10, (1221086), 10.3389/fmed.2023.1221086) 126
Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease 125
Can Mediterranean Diet Have a Positive Impact on Kidney Health? A Pending Answer to a Long-Time Question 119
Association between the uremic toxins indoxyl-sulfate and p-cresyl-sulfate with sarcopenia and malnutrition in elderly patients with advanced chronic kidney disease 117
Palliative and supportive dialysis: State of the art and recommendations for good clinical practice 116
A new CHA2DS2VASC score integrated with estimated glomerular filtration rate, left ventricular hypertrophy, and pulse pressure is highly effective in predicting adverse cardiovascular outcome in chronic kidney disease 115
The Number of Medications Is Associated with Fractures in a Population of Dialyzed Older Patients with Frailty 115
Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial 112
Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction 110
Advanced glycation end products (Age) and soluble forms of age receptor: Emerging role as mortality risk factors in CKD 109
MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD 106
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 103
Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation 102
Endothelial dysfunction in chronic kidney disease: Determinant of susceptibility to end-organ damage and therapeutic response 97
Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress 97
Calcium carbonate-enriched cheese to improve nutrition, compliance and phosphorus control in patients on kidney replacement therapy 97
Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease 97
Optimizing global risk evaluation in primary hypertension: The role of microalbuminuria and cardiovascular ultrasonography 94
Frailty index and adverse outcomes in older patients in haemodialysis 94
Beyond cohort selection: An analytics-enabled i2b2 93
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension 92
Economic evaluation of angiotensin receptor blockers in type 2 diabetes, hypertension, and nephropathy 92
Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease 92
Nutritional Strategies to Prevent Muscle Loss and Sarcopenia in Chronic Kidney Disease: What Do We Currently Know? 92
Frailty phenotype and multi-domain impairments in older patients with chronic kidney disease 91
Plasma adiponectin levels in chronic kidney disease patients: Relation with molecular inflammatory profile and metabolic status 91
Microalbuminuria, cardiovascular, and renal risk in primary hypertension 89
Vulvar pyoderma gangrenosum with renal involvement 87
Use of the Frailty Index in Older Persons With Chronic Kidney Disease 85
Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study 85
Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: A pilot study 85
Patients with Hypertensive Nephropathy and Chronic Kidney Disease Might Not Benefit from Strict Blood Pressure Control 84
Vitamin D and subclinical cardiac damage in a cohort of kidney transplanted patients: a retrospective observational study 84
Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship 84
Metabolic acidosis in renal transplantation: neglected but of potential clinical relevance 83
In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition 82
Pulse pressure and subclinical cardiovascular damage in primary hypertension 82
Malnutrition and inflammation are associated with severity of depressive and cognitive symptoms of old patients affected by chronic kidney disease 81
MCP1 Inverts the Correlation between FGF23 and Omega 6/3 Ratio: Is It Also True in Renal Transplantation? 81
Mild Renal Dysfunction and Cardiovascular Risk in Hypertensive Patients 80
Changes over time in ambulatory blood pressure and cardiac parameters predict cardiovascular outcome of patients with CKD and low cardiovascular morbidity 80
Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study 79
Associations Between Cholesterol and Fatty Acid Profile on the Severity of Depression in Older Persons With Nondialysis Chronic Kidney Disease 77
Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats 77
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 76
Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice 75
Frailty in kidney transplantation: a review on its evaluation, variation and long-term impact 75
The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism 75
Prevention and treatment of diabetic nephropathy: The program for Irbesartan mortality and morbidity evaluation 75
Mild renal dysfunction and renal vascular resistance in primary hypertension 74
Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized rats 74
Renal and cardiovascular protection in type 2 diabetes mellitus: Angiotensin II receptor blockers 73
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: An artificial neural network-based approach 73
Sarcopenia is associated with malnutrition but not with systemic inflammation in older persons with advanced CKD 73
Is there an association between severity of illness and psychiatric symptoms in patients with chronic renal failure? 72
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 72
Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation 72
The role of angiotensin II AT1 receptor antagonists in nephroprotection and cardioprotection in type 2 diabetes mellitus 70
Treatment of hyperuricemia in CKD 70
Creatinine clearance and signs of end-organ damage in primary hypertension 69
Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension 69
AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease 66
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension 62
Cardiovascular and Renal Risk Assessment as a Guide for Treatment in Primary Hypertension 60
Totale 9.125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/202232 5 8 6 2 1 5 0 0 2 0 1 2
2022/202357 5 14 9 8 9 7 0 0 2 1 0 2
2023/202414 1 2 2 1 0 5 0 0 2 0 0 1
2024/20252.461 1 6 2 2 3 1 15 4 558 541 331 997
2025/20266.502 574 790 606 892 361 246 576 352 547 443 354 761
Totale 9.125